Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
暂无分享,去创建一个
D. P. Spolidorio | J. Sardi | R. S. Francisconi | E. Bordini | Patrícia Milagros Maquera Huacho | C. Tonon
[1] J. C. Junqueira,et al. Study of Microbial Interaction Formed by "Candida krusei" and "Candida glabrata": "In Vitro" and "In Vivo" Studies. , 2017, Brazilian dental journal.
[2] A. Delpisheh,et al. Anti-fungal resistance in candida isolated from oral and diaper rash candidiasis in neonates , 2014, Bioinformation.
[3] I. Ahmad,et al. Sub-MICs of Carum copticum and Thymus vulgaris influence virulence factors and biofilm formation in Candida spp , 2014, BMC Complementary and Alternative Medicine.
[4] L. Samaranayake,et al. Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals , 2014, Mycopathologia.
[5] C. Rossa Junior,et al. Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages , 2014, Inflammation Research.
[6] B. Sadowska,et al. Enzymatic profile, adhesive and invasive properties of Candida albicans under the influence of selected plant essential oils. , 2014, Acta Biochimica Polonica.
[7] N. Manzoor,et al. Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] T. Riley,et al. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil. , 2012, Medical mycology.
[9] J. F. Höfling,et al. Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. , 2012, Medical mycology.
[10] J. Bagg,et al. Antifungal, Cytotoxic, and Immunomodulatory Properties of Tea Tree Oil and Its Derivative Components: Potential Role in Management of Oral Candidosis in Cancer Patients , 2012, Front. Microbio..
[11] C. Biçmen,et al. Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. , 2012, The new microbiologica.
[12] R. Gonçalves,et al. Periodontal conditions and prevalence of putative periodontopathogens and Candida spp. in insulin-dependent type 2 diabetic and non-diabetic patients with chronic periodontitis--a pilot study. , 2011, Archives of oral biology.
[13] X. S. Passos,et al. Effects of Antifungal Agents in Sap Activity of Candida albicans Isolates , 2010, Mycopathologia.
[14] A. Cione,et al. Development and validation of an HPLC method for stability evaluation of nystatin , 2010 .
[15] G. Cristalli,et al. Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-cariogenic formulations. , 2009, Fitoterapia.
[16] Mrudula Patel,et al. The effect of Dodonaea viscosa var. angustifolia on Candida albicans proteinase and phospholipase production and adherence to oral epithelial cells. , 2009, Journal of ethnopharmacology.
[17] Shujuan Sun,et al. In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods , 2007, Antimicrobial Agents and Chemotherapy.
[18] W. Leung,et al. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. , 2007, Journal of medical microbiology.
[19] A. Cassone,et al. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species , 2006, BMC infectious diseases.
[20] T. Riley,et al. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties , 2006, Clinical Microbiology Reviews.
[21] J. Trouillas,et al. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[22] T. Riley,et al. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. , 2004, The Journal of antimicrobial chemotherapy.
[23] J. Perfect,et al. Combination Antifungal Therapy , 2004, Antimicrobial Agents and Chemotherapy.
[24] H. Yamaguchi,et al. Effect of Sealing and Tween 80 on the Antifungal Susceptibility Testing of Essential Oils , 2001, Microbiology and immunology.
[25] A. Fusco-Almeida,et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. , 2013, Journal of medical microbiology.
[26] R. Cordeiro,et al. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. , 2013, Medical mycology.
[27] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .